Physician profile
Loc Pham
NPI 1548248685
$787.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.78 · 2020: $119 · 2021: $31.05 · 2022: $51.97 · 2023: $21.60 · 2024: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $228.00 | 2024 | Proclaim |
| Edwards Lifesciences Corporation | $143.73 | 2019-2022 | |
| Medtronic, INC. | $132.05 | 2024 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Becton, Dickinson and Company | $45.39 | 2024 | Hemosphere |
| Mallinckrodt Hospital Products INC. | $27.82 | 2020 | |
| Chiesi USA, INC. | $27.51 | 2020 | |
| Mindray Ds USA, INC. | $23.02 | 2021 | |
| Ge Healthcare | $21.60 | 2023 | |
| Heron Therapeutics, INC. | $13.53 | 2022 | |
| Ambu INC. | $8.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loc Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.